'Bookmarks' on stem cell genes preserve cell identity

Stem cells preserve their identities after cell division by using a series of protein "bookmarks" on their genes, according to new research published by scientists at Weill Cornell Medicine.

Researchers ID drug that blocks some blood cancers

A compound identified by Weill Cornell Medicine scientists inhibits the growth of a rare blood cancer found in people with HIV-AIDS.

Weill Cornell Medicine doctoral students present their work

At the 37th Annual Vincent du Vigneaud Memorial Symposium April 18, posters displayed research from students at every stage along the path to a doctorate.

Study reveals how HIV virus destroys lung tissue

Up to 30 percent of HIV patients who are appropriately treated with antiretroviral therapies develop emphysema. New research from Weill Cornell Medicine investigators has uncovered a mechanism that might explain why this lung damage occurs.

Students learn to commercialize medical technologies

The Bench to Bedside Initiative program, part of Weill Cornell Medicine's entrepreneurship lab, helps medical and doctoral students, clinicians and researchers launch technologies into startups.

New method more accurately models colorectal cancer

Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center researchers have developed a preclinical model of colorectal cancer in which the disease forms in the correct anatomical location.

Symposium examines threat of antimicrobial resistance

Dr. Arjun Srinivasan of the CDC delivered the keynote lecture at the symposium, "Antimicrobial Resistance: Research Synergies in Human and Animal Medicine," on Cornell's Ithaca campus May 4.

Yimon Aye awarded young investigator cancer research prize

Yimon Aye, assistant professor of chemistry and chemical biology, has won the Pershing Square Sohn Prize for Young Investigators in Cancer Research. The prize is $600,000 over three years.

Collaborative startup will monitor pathogens in hospital settings

Biotia, a startup offering microbial surveillance for hospitals, is a joint venture between researchers at Weill Cornell Medicine and Cornell Tech, founded through the Runway Startup program at the Jacobs Technion-Cornell Institute at Cornell Tech.